Establishment and Application of an Indirect ELISA for the Detection of Antibodies to Porcine Streptococcus suis Based on a Recombinant GMD Protein

Simple Summary This study developed an indirect ELISA (GMD-ELISA) to detect the Streptococcus suis (S. suis) antibody. The antigen—antibody response was optimized using checkerboard titration. This method has strong specificity and can detect the main epidemic strains of S. suis in China—type 2, type 7, and type 9—compared with using the commercial Streptococcus suis ELISA type 2 kit. The GMD-ELISA method has high sensitivity and good repeatability. The novel GMD-ELISA method provides technical support for rapid diagnosis and epidemiological investigation. Abstract S. suis is an important zoonotic pathogen from sick and recessive carrier pigs that poses a serious threat to animal husbandry production and public health. It usually causes horizontal transmission among pigs. The morbidity and mortality of this disease are very high. Human infection is caused through direct or indirect contact with sick pigs. The two large-scale outbreaks in China were due to the outbreak of S. suis on pig farms, which spread to human infection; thus, detecting S. suis in pig herds is crucial. At present, the commercial S. suis ELISA type 2 kits on the market can only detect single serotypes, high probabilities of interaction reactions, and biosafety risks when using inactivated S. suis as an antigen. Phosphate-3-glyceraldehyde dehydrogenase (GAPDH), muramidase-released protein (MRP), and dihydrolipoamide dehydrogenase (DLDH) are important S. suis type 2, S. suis type 7, and S. suis type 9 protective antigens. This study purified the GMD protein (B-cell-dominant epitopes of GAPDH, MRP, and DLDH antigens) and used a diverse combination of dominant epitopes of the multiple different antigens as coated antigens, improving the sensitivity and safety of the indirect ELISA experiments. An indirect ELISA method (GMD-ELISA) was developed for detecting S. suis antibodies. The antigen—antibody response was optimized using checkerboard titration. The results of testing using ELISA for Salmonella enterica (S. enterica), Escherichia coli (E. coli), Staphylococcus aureus (SA), and Streptococcus pyogenes (S. pyogenes) were all negative, indicating that this method had strong specificity. The results were still positive when the dilution ratio of S. suis-positive serum reached 1:6, 400, thus indicating that the method had high sensitivity. The results of the reproducibility assay for indirect ELISA showed that the intra-assay coefficient of variation and the inter-assay coefficient of variation were less than 10%, indicating that the method had good repeatability. We investigated the seroprevalence of S. suis in 167 serum samples collected in East China, and 33.5% of the samples were positive for antibodies against S. suis, indicating that the prevalence of S. suis is high in pig farms in Eastern China. The novel GMD-ELISA is a convenient, sensitive, and specific diagnostic method that provides technical support for rapid diagnosis and epidemiological investigation.

[1]  N. Párraga-Niño,et al.  Clinical and Epidemiological Characteristics of Streptococcus suis Infections in Catalonia, Spain , 2021, Frontiers in Medicine.

[2]  M. Gottschalk,et al.  Stochastic Assessment of the Economic Impact of Streptococcus suis-Associated Disease in German, Dutch and Spanish Swine Farms , 2021, Frontiers in Veterinary Science.

[3]  S. Roytrakul,et al.  Streptococcus suis serotyping by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry , 2021, PloS one.

[4]  JianHe Sun,et al.  TLR4 Agonist Combined with Trivalent Protein JointS of Streptococcus suis Provides Immunological Protection in Animals , 2021, Vaccines.

[5]  Jian Sun,et al.  Rapid Detection of mrp, epf, and sly Genes by Loop-Mediated Isothermal Amplification in Streptococcus suis. , 2021, Foodborne pathogens and disease.

[6]  W. Fang,et al.  Stk and Stp1 participate in Streptococcus suis serotype 2 pathogenesis by regulating capsule thickness and translocation of certain virulence factors. , 2020, Microbial pathogenesis.

[7]  B. Guss,et al.  Streptococcus suis in Swedish grower pigs: occurrence, serotypes, and antimicrobial susceptibility , 2020, Acta Veterinaria Scandinavica.

[8]  N. Fatmawati,et al.  Streptococcus suis–Associated Meningitis, Bali, Indonesia, 2014–2017 , 2019, Emerging infectious diseases.

[9]  N. Fittipaldi,et al.  Critical Streptococcus suis Virulence Factors: Are They All Really Critical? , 2017, Trends in microbiology.

[10]  M. Gottschalk,et al.  Serotypes of Streptococcus suis isolated from healthy pigs in Phayao Province, Thailand , 2017, BMC Research Notes.

[11]  Shijin Jiang,et al.  Development of an Indirect Dot-PPA-ELISA using glutamate dehydrogenase as a diagnostic antigen for the rapid and specific detection of Streptococcus suis and its application to clinical specimens , 2017, Antonie van Leeuwenhoek.

[12]  S. Hamada,et al.  First human case report of sepsis due to infection with Streptococcus suis serotype 31 in Thailand , 2015, BMC Infectious Diseases.

[13]  T. Sekizaki,et al.  Development of an appropriate PCR system for the reclassification of Streptococcus suis. , 2014, Journal of microbiological methods.

[14]  Chengping Lu,et al.  Novel Variant Serotype of Streptococcus suis Isolated from Piglets with Meningitis , 2014, Applied and Environmental Microbiology.

[15]  Jianguo Xu,et al.  Streptococcus suis, an important pig pathogen and emerging zoonotic agent—an update on the worldwide distribution based on serotyping and sequence typing , 2014, Emerging Microbes & Infections.

[16]  Jing Wang,et al.  Development of colloidal gold-based immunochromatographic assay for rapid detection of Streptococcus suis serotype 2. , 2010, Veterinary immunology and immunopathology.

[17]  Xuehui Cai,et al.  Characterization of Streptococcus suis isolates from the diseased pigs in China between 2003 and 2007. , 2009, Veterinary microbiology.

[18]  D. Grenier,et al.  Fibrinogen Induces Biofilm Formation by Streptococcus suis and Enhances Its Antibiotic Resistance , 2008, Applied and Environmental Microbiology.

[19]  J. Farrar,et al.  Streptococcus suis meningitis in adults in Vietnam. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  M. Gottschalk,et al.  Streptococcus suis infections in humans: the Chinese experience and the situation in North America , 2007, Animal Health Research Reviews.

[21]  Xiao-Guang Chen,et al.  Streptococcus suis: an emerging zoonotic pathogen. , 2007, The Lancet. Infectious diseases.

[22]  Weizhong Yang,et al.  Streptococcal Toxic Shock Syndrome Caused by Streptococcus suis Serotype 2 , 2006, PLoS medicine.

[23]  Weizhong Yang,et al.  Human Streptococcus suis Outbreak, Sichuan, China , 2006, Emerging infectious diseases.

[24]  Weizhong Yang,et al.  Streptococcal Toxic Shock Syndrome Caused by Streptococcus suis Serotype 2 , 2006, PLoS Medicine.

[25]  Weizhong Yang,et al.  [Matched case-control study for risk factors of human Streptococcus suis infection in Sichuan Province, China]. , 2005, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[26]  M. Gottschalk,et al.  Cloning and purification of the Streptococcus suis serotype 2 glyceraldehyde-3-phosphate dehydrogenase and its involvement as an adhesin. , 2004, Veterinary microbiology.

[27]  Gary L. Cromwell,et al.  WHY AND HOW ANTIBIOTICS ARE USED IN SWINE PRODUCTION , 2002, Animal biotechnology.

[28]  M. Gottschalk,et al.  The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. , 2000, Veterinary microbiology.

[29]  R. Rodríguez,et al.  Preformulation study of the vaccine candidate P64k against Neisseria meningitidis , 1999, Biotechnology and applied biochemistry.

[30]  P. Vignon,et al.  Recurrent Septic Shock Due to Streptococcus suis , 1998, Journal of Clinical Microbiology.

[31]  M. Chengappa,et al.  Streptococcus Suis: Past and Present , 1997, Veterinary Research Communications.

[32]  M. Gottschalk,et al.  Detection of antibodies against Streptococcus suis capsular type 2 using a purified capsular polysaccharide antigen-based indirect ELISA. , 1996, Veterinary microbiology.

[33]  Y. Kataoka,et al.  An enzyme-linked immunosorbent assay (ELISA) for the detection of antibody against Streptococcus suis type 2 in infected pigs. , 1996, The Journal of veterinary medical science.

[34]  M. Vignon,et al.  Streptococcus suis meningitis. A severe noncompensated occupational disease. , 1992, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[35]  H. Wisselink,et al.  Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype , 1992, Infection and immunity.

[36]  E. Zimmerer,et al.  Conjugation of antibiotic resistance in Streptococcus suis. , 1992, Veterinary microbiology.

[37]  M. Jacques,et al.  Description of 14 new capsular types of Streptococcus suis , 1989, Journal of clinical microbiology.

[38]  I. Robertson,et al.  Occupational exposure to Streptococcus suis type 2 , 1989, Epidemiology and Infection.

[39]  Huanchun Chen,et al.  Recent Proceedings on Prevalence and Pathogenesis of Streptococcus suis. , 2019, Current issues in molecular biology.

[40]  M. Riley,et al.  Bacteriocins: evolution, ecology, and application. , 2002, Annual review of microbiology.

[41]  F. A. Clifton-Hadley Streptococcus suis type 2 infections. , 1983, The British veterinary journal.